Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls

1 week ago 7

The Fly

Tue, April 14, 2026 astatine 8:53 AM CDT 4 min read

The astir talked astir and marketplace moving probe calls astir Wall Street are present successful 1 place. Here are today's probe calls that investors request to know, arsenic compiled by The Fly.

Top 5 Upgrades:

UBS upgraded Tesla (TSLA) to Neutral from Sell with an unchanged terms people of $352. The steadfast says existent stock levels "more evenly balance" Tesla's near-term request challenges and concern play with its semipermanent carnal AI opportunity. UBS besides upgraded Ford (F) to Buy from Neutral with an unchanged terms people of $15.
Deutsche Bank upgraded General Motors (GM) to Buy from Hold with a terms people of $90, up from $83, pursuing the caller pullback successful shares. The steadfast views caller weakness arsenic an "attractive introduction constituent to summation vulnerability to a imaginable multi-year re-rate story."
Seaport Research upgraded Crocs (CROX) to Buy from Neutral with a $135 terms target. The company's request has picked up this spring, partially owed to beardown sandal demand, the steadfast tells investors successful a probe note. Seaport Research besides upgraded Birkenstock (BIRK) and VF Corp. (VFC) to Buy from Neutral.
Jefferies upgraded Bloom Energy (BE) to Hold from Underperform with a terms people of $187, up from $97, aft the institution announced a 1.2GW bid with Oracle (ORCL), with imaginable for an further 1.6GW implicit time.
Piper Sandler upgraded Biogen (BIIB) to Overweight from Neutral with a terms people of $214, up from $177. The company's acquisition of Apellis Pharmaceuticals (APLS) brings caller drugs to capable the spread created by its declining bequest aggregate sclerosis franchise, the steadfast tells investors successful a probe note.

Top 5 Downgrades:

Piper Sandler downgraded Monday.com (MNDY) to Neutral from Overweight with a terms people of $85, down from $100, citing a "challenged" collaboration market. The steadfast says 2026 "has been unsmooth for endeavor software." Piper Sandler besides downgraded Asana (ASAN) to Neutral from Overweight with a terms people of $7, down from $9.
Craig-Hallum downgraded Fastly (FSLY) to Hold from Buy with a $24 terms target. The steadfast sees respective factors weighing connected the guardant year, including lapping casual compares, and elevated capex walk which volition interaction margins.
Barclays downgraded Revvity (RVTY) to Equal Weight from Overweight with a terms people of $95, down from $118. The steadfast sees borderline hazard heading into the company's Q1 study arsenic good arsenic imaginable competitory threats to travel cytometry reagents from Waters.
Barclays downgraded Qiagen (QGEN) to Equal Weight from Overweight with a terms people of $44, down from $58. The steadfast present sees the company's takeout imaginable arsenic little likely.
BofA downgraded Omega Healthcare (OHI) to Underperform from Neutral with a terms people of $46, down from $52. The steadfast is reducing its FY26 AFFO estimation successful enactment with the Street and lowering its AFFO multiple, citing heightened competitory dynamics, regulatory pressures, and plus prime considerations comparative to peers.